ANTM - Anthem, Inc.
| Previous Close | 280.45 |
| Open | 279.61 |
| Bid | 274.43 x 1100 |
| Ask | 274.71 x 1200 |
| Day's Range | 271.68 - 281.29 |
| 52 Week Range | 215.52 - 300.57 |
| Volume | 676,596 |
| Avg. Volume | 1,383,015 |
| Market Cap | 70.979B |
| Beta (3Y Monthly) | 1.07 |
| PE Ratio (TTM) | 15.91 |
| EPS (TTM) | 17.25 |
| Earnings Date | Jan 30, 2019 |
| Forward Dividend & Yield | 3.00 (1.07%) |
| Ex-Dividend Date | 2018-12-04 |
| 1y Target Est | 322.42 |
Zacks•7 hours agoThe Zacks Analyst Blog Highlights: Anthem, Ensign, NeoGenomics, Merit Medical Systems and Medpace
The Zacks Analyst Blog Highlights: Anthem, Ensign, NeoGenomics, Merit Medical Systems and Medpace
GuruFocus.com•yesterday5 Stocks These Former Tiger Cubs Agree On
Legendary investor Julian Robertson (Trades, Portfolio) is known not just for his leadership of Tiger Management, but also for taking a group of proteges under his wing. Warning! GuruFocus has detected 8 Warning Signs with MSFT. An example of this is Lee Ainslie (Trades, Portfolio), who now heads up Maverick Capital, and Andreas Halvorsen (Trades, Portfolio), leader of Viking Global Investors.
- Zacks•yesterday
5 Healthcare Bets to Stay in Investors Good Books Next Year
Based on a few key factors, we zero in on five stocks that show promise to retain the bull run in 2019.
Zacks•2 days agoCan a Divided Congress Boost Healthcare Stocks? 4 Picks
A divided Congress ensures Obamacare stays in place.
- Zacks•3 days ago
Moody's Downgrades Acadia's (ACHC) Outlook, Affirms Ratings
Acadia Healthcare (ACHC) receives rating actions from Moody's. Outlook down to negative from stable.
Markit•3 days agoSee what the IHS Markit Score report has to say about Anthem Inc.
Anthem Inc NYSE:ANTM
Zacks•4 days agoThe Zacks Analyst Blog Highlights: Eli Lilly, Anthem, BlackRock, CME Group and Southern Company
The Zacks Analyst Blog Highlights: Eli Lilly, Anthem, BlackRock, CME Group and Southern Company
Zacks•4 days agoIs Anthem (ANTM) Stock Outpacing Its Medical Peers This Year?
Is (ANTM) Outperforming Other Medical Stocks This Year?
- Insider Monkey•5 days ago
Is Anthem Inc (ANTM) A Good Stock To Buy?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities over the years (that’s why their assets under management continue to swell). We believe hedge fund sentiment should serve as a crucial tool of an […]
- Zacks•8 days ago
Quality ETFs & Stocks to Outperform Amid Volatility
We have highlighted five quality ETFs & stocks that could enjoy smooth trading and generate market-beating returns in a rocky market.
- Zacks•10 days ago
Anthem (ANTM) Stock Moves -1.12%: What You Should Know
In the latest trading session, Anthem (ANTM) closed at $292.92, marking a -1.12% move from the previous day.
- Zacks•10 days ago
Zacks.com featured highlights include: Intel, Thermo Fisher, Marcus, Anthem and ArcBest
Zacks.com featured highlights include: Intel, Thermo Fisher, Marcus, Anthem and ArcBest
- Zacks•10 days ago
The Zacks Analyst Blog Highlights: Anthem, HCA, Dr. Reddy's and UnitedHealth
The Zacks Analyst Blog Highlights: Anthem, HCA, Dr. Reddy's and UnitedHealth
- Zacks•10 days ago
HMO Industry Surges Almost 4 Times S&P 500: 4 Picks
Health insurers gains on strong industry and operating conditions, the same should continue in 2019.
- Zacks•11 days ago
Is Anthem (ANTM) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- Zacks•11 days ago
Is Anthem (ANTM) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- Zacks•11 days ago
Healthcare Takes Wall Street Lead: 4 Picks
Continuous innovation and research in the field of biotechnology and an increasingly aged population in the United States are helping whet appetite for healthcare shares.
- Zacks•11 days ago
5 Solid Dividend Growth Stocks for Your Portfolio
Dividend-paying securities are the major source of consistent income for investors when returns from the equity market are at risk.
Market Realist•11 days agoExpress Scripts Holding Stock Has Risen 36% in 2018
On November 29, Express Scripts Holding’s (ESRX) stock price closed at $101.22, which is ~5% growth from the close of $96.81 on November 23. Express Scripts Holding’s stock price grew from $74.64 at the close of the market on December 29, 2017, to $101.22 at the close of the market on November 29, which reflects ~36% YTD (year-to-date) growth.
- American City Business Journals•12 days ago
Office Deal of the Year: Anthem Technology Center takes top NAIOP Georgia honors
A construction start on a new Midtown office tower for the technology unit of a major national healthcare company has been awarded NAIOP Georgia chapter’s Office Deal of the Year.
- Zacks•14 days ago
HCA (HCA) Hits 52-Week High, Can the Run Continue?
HCA (HCA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- Zacks•15 days ago
Humana to Gain from Share Buyback, Raise Membership Outlook
Humana (HUM) announces accelerated share buyback and gears up for increased Medicare Advantage membership.
- Zacks•15 days ago
6 Reasons Why You Should Add Anthem Stock to Your Portfolio
Riding high on robust results, strong capital efficiency and buyouts; Anthem (ANTM) holds great prospects to reap returns for investors.
- Zacks•15 days ago
5 Stocks With Impressive PEG Ratio for Value Investors
According to Warren Buffett, going by the fundamentals of value investing while picking undervalued stocks, investors need to focus on their earnings growth potential.
- GlobeNewswire•15 days ago
Report: Developing Opportunities within Teleflex, Anthem, Crown Castle International, MSCI, GCI Liberty, and Akebia Therapeutics — Future Expectations, Projections Moving into 2018
NEW YORK, Nov. 29, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
